In the News

Gen9, Synthetic Biology Startup, Snags $21M from Agilent

  • April 24, 2013

Scientists have been able to order up custom-synthesized genes on demand for quite a few years now.

READ MORE

Kraft Group-backed Gen9 gets $21M from Agilent

  • April 24, 2013

Gen9 Inc., maker of the first ‘fab’ for synthetic biology, which emerged from stealth mode late last year, has secured $21 million from Agilent Technologies.

READ MORE

Gen9 lands $21M investment from Agilent Technologies

  • April 24, 2013

Cambridge-based Gen9 Inc. said today it has received a $21 million investment from Agilent Technologies to further invest in product development and expand the “commercial infrastructure” for its synthetic biology business.

READ MORE

Agilent Makes $21M Investment in Gen9

  • April 24, 2013

Full-text access for registered users only.

READ MORE

Agilent Takes $21M Stake in Gen9

  • April 24, 2013

Agilent Technologies took an equity stake in synthetic biology pioneer Gen9 by closing on a $21 million investment in the developer of scalable technologies for synthesizing genes, the companies said today.

READ MORE

Next-Gen Gene Synthesis Opens a World of New Possibilities

  • March 1, 2013

A discussion with synthetic biology pioneers Drew Endy, George Church, and David Baker.

READ MORE

3 Synthetic Biology Stocks That Can Help You Grow in 2014 (and Beyond)

  • January 23, 2013

After seeing the exploding need for synthetic genes and developing an industry-leading platform for creating short, single-stranded DNA (oligonucleotides), the company made a $21 million investment in DNA synthesis start-up Gen9 that combined each company's...

READ MORE

3 Ways the $1,000 Human Genome Can Revolutionize Science and Medicine As We Know It

  • January 15, 2013

Cheaper sequencing costs will ultimately provide an added incentive to invest heavily in synthesis technologies. How far can costs drop?

READ MORE

Top 10 Innovations 2012

  • December 13, 2012

"Brings the cost and speed of DNA synthesis down to the point where entire vectors can be designed and assembled from scratch. A critical component needed to make synthetic biology a reality." 

READ MORE

UW’s brave (and bright!) new lab for molecular engineering

  • September 4, 2012

"The UW works with a Massachusetts company, Gen9, that has come up with a process to make genes on a very large scale."

READ MORE